• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Eli Lilly agreed to buy Calytrix Bio for US$1.5 billion in its push against blood cancer

FinanceInternationalLa República15 s readAI summary

Eli Lilly agreed to acquire Calytrix Bio for US$1.5 billion, a deal the drugmaker frames within its push against blood cancer. Calytrix Bio was founded in 2025 by JP Morgan Life Sciences Private Capital and launched with funding provided by JP Morgan's venture capital division and Westlake BioPartners.

Read the full story at La República

IASummary generated by artificial intelligence from a story by La República. It may contain errors: the original source prevails.

More flashes